Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Discover the pros and cons of long term versus short term investing. Make informed decisions based on your financial goals.
28,015 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Investors ask whether to buy Domino's stock before a major investor update. This guide breaks down the decision, back...
A recent insider move at Lindblad Expeditions Holdings drew attention from investors. This article breaks down what h...
Redwire stock swung sharply during today’s session, leaving investors with questions about its business model and gro...
General Motors stock surged 65% in the last year, leaving investors wondering if the rally has legs. This article cut...
Broadcom is riding a powerful AI wave, with revenue in key AI-adjacent areas jumping. Yet the stock moved lower after...
When kevin warsh's inflation testimony landed, traders priced an 86% chance of a Fed rate hold. This article breaks d...
A notable stake by 140 Summer Partners LP in Acuity Brands is turning heads in the investing world. This article brea...
Geopolitical tensions with Iran have rattled energy markets, sending LNG-focused stocks lower while underscoring long...
A veteran wealth manager bets international exposure through a broad non-U.S. ETF to diversify risk and tap growth ou...
On days when upbeat earnings flood the headlines, the Nasdaq sometimes slips instead of rallying. This article explai...
This guide dives into groupon (grpn) 2026 earnings, breaking down the first-quarter insights, revenue streams, and ke...